Bio-Techne (TECH) Gross Profit Growth (3y) (2012 - 2026)

Bio-Techne (TECH) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 54.36%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.16%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.86%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 79.18%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 1.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00%
Dec 31, 2025 1.42%
Sep 30, 2025 1.56%
Jun 30, 2025 -0.26%
Mar 31, 2025 2.12%
Dec 31, 2024 1.82%
Sep 30, 2024 2.29%
Jun 30, 2024 4.94%
Mar 31, 2024 6.73%
Dec 31, 2023 5.38%
Sep 30, 2023 10.37%
Jun 30, 2023 21.79%
Mar 31, 2023 15.84%
Dec 31, 2022 14.73%
Sep 30, 2022 14.89%
Jun 30, 2022 16.03%
Mar 31, 2022 17.37%
Dec 31, 2021 17.57%
Sep 30, 2021 16.70%
Jun 30, 2021 12.93%